Advertisement
Advertisement
U.S. markets open in 5 hours 50 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Asensus Surgical, Inc. (ASXC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.6850-0.0450 (-6.16%)
At close: 04:00PM EDT
0.6800 -0.00 (-0.73%)
After hours: 07:44PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close0.7300
Open0.7162
Bid0.0000 x 3100
Ask0.0000 x 1400
Day's Range0.6600 - 0.7243
52 Week Range0.3500 - 2.3700
Volume1,726,388
Avg. Volume2,522,390
Market Cap162.153M
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
EPS (TTM)-0.2740
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ASXC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Asensus Surgical, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more
  • GlobeNewswire

    Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022

    RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2022. Recent Highlights Over 670 procedures were performed globally during the quarter, representing growth of 34% over the prior year quarter, including 77% growth in

  • GlobeNewswire

    Asensus Surgical Announces Sale of Senhance Robotic System

    Senhance System to be placed at hospital in the Commonwealth of Independent States Senhance Surgical System Performance-Guided Surgery™ Leveraging the Performance-Guided Surgery™ framework, the Senhance Surgical System advances clinical intelligence by providing surgeons with augmented intelligence and digital tools to perform consistently superior surgery. RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that

  • GlobeNewswire

    Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 8, 2022

    RESEARCH TRIANGLE PARK, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 second quarter financial and operating results after the market closes on Monday, August 8, 2022. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day.

Advertisement
Advertisement